Endogenous peptides as risk markers to assess the development of insulin resistance.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Endogenous peptides as risk markers to assess the development of insulin resistance.
- Published In:
- Peptides, 51, 9-14 (2014)
- Authors:
- Fang, Penghua, Shi, Mingyi, Yu, Mei, Guo, Lili, Bo, Ping, Zhang, Zhenwen
- Database ID:
- RPEP-02381
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02381APA
Fang, Penghua; Shi, Mingyi; Yu, Mei; Guo, Lili; Bo, Ping; Zhang, Zhenwen. (2014). Endogenous peptides as risk markers to assess the development of insulin resistance.. Peptides, 51, 9-14. https://doi.org/10.1016/j.peptides.2013.10.025
MLA
Fang, Penghua, et al. "Endogenous peptides as risk markers to assess the development of insulin resistance.." Peptides, 2014. https://doi.org/10.1016/j.peptides.2013.10.025
RethinkPeptides
RethinkPeptides Research Database. "Endogenous peptides as risk markers to assess the developmen..." RPEP-02381. Retrieved from https://rethinkpeptides.com/research/fang-2014-endogenous-peptides-as-risk
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.